Krauze, A. V., Mackey, M., Rowe, L., Chang, M. G., Holdford, D. J., Cooley, T., . . . Camphausen, K. (2018). Late toxicity in long-term survivors from a phase 2 study of concurrent radiation therapy, temozolomide and valproic acid for newly diagnosed glioblastoma. Neuro-Oncology Practice, 5(4), 246. https://doi.org/10.1093/nop/npy009
Chicago Style (17th ed.) CitationKrauze, Andra V., Megan Mackey, Lindsay Rowe, Michal G. Chang, Diane J. Holdford, Theresa Cooley, Joanna Shih, Philip J. Tofilon, and Kevin Camphausen. "Late Toxicity in Long-term Survivors from a Phase 2 Study of Concurrent Radiation Therapy, Temozolomide and Valproic Acid for Newly Diagnosed Glioblastoma." Neuro-Oncology Practice 5, no. 4 (2018): 246. https://doi.org/10.1093/nop/npy009.
MLA (9th ed.) CitationKrauze, Andra V., et al. "Late Toxicity in Long-term Survivors from a Phase 2 Study of Concurrent Radiation Therapy, Temozolomide and Valproic Acid for Newly Diagnosed Glioblastoma." Neuro-Oncology Practice, vol. 5, no. 4, 2018, p. 246, https://doi.org/10.1093/nop/npy009.